CoChat
Sign Up
Cited by 199Alcohol Consumption and Health EffectsDiet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.

Open access
Shelmet, J J, Reichard, G A, Skutches, C L, Hoeldtke, R D, Owen, O E, Boden, G·1988·Journal of Clinical Investigation
DOI 10.1172/jci113428PMC PMC329642
Open this paper in CoChat — free accountOpen PDF

Abstract

To study the mechanism of the diabetogenic action of ethanol, ethanol (0.75 g/kg over 30 min) and then glucose (0.5 g/kg over 5 min) were infused intravenously into six normal males. During the 4-h study, 21.8 +/- 2.1 g of ethanol was metabolized and oxidized to CO2 and H2O. Ethanol decreased total body fat oxidation by 79% and protein oxidation by 39%, and almost completely abolished the 249% rise in carbohydrate (CHO) oxidation seen in controls after glucose infusion. Ethanol decreased the basal rate of glucose appearance (GRa) by 30% and the basal rate of glucose disappearance (GRd) by 38%, potentiated glucose-stimulated insulin release by 54%, and had no effect on glucose tolerance. In hyperinsulinemic-euglycemic clamp studies, ethanol caused a 36% decrease in glucose disposal. We conclude that ethanol was a preferred fuel preventing fat, and to lesser degrees, CHO and protein, from being oxidized. It also caused acute insulin resistance which was compensated for by hypersecretion of insulin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci113428

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 2

  1. Faloona, G. R., and R. H. Unger. 1974. Glucagon. In Methods of Hormone Radioimmunoassay. B. M. Jaffe, and H. R. Behrman, editors. Academic Press, Inc., New York. 317-330.
  2. Lieber, C. S. 1982. Ethanol and lipid disorders, including fatty liver, hyperlipemia and arterosclerosis. In Medical Disorders of Alco- holism: Pathogenesis and Treatment. L. H. Smith, editor. W. B. Saunders Co., Philadelphia. 14 1-177.

Cited by

Sorted by citations

Items 101–199 of 199

Related

See all

Metadata

Authors
Shelmet, J. J., Reichard, G. A., Skutches, C. L., Hoeldtke, R. D., Owen, O. E., & Boden, G.
Affiliations
  • Temple University Hospital (US)
  • Lankenau Medical Center (US)
ORCID
Reichard, G A
Venue
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Published
1988-04-01
Volume
81
Issue
4
Pages
1137-1145
ISSN
0021-9738 (ISSN-L)
DOI
10.1172/jci113428
PMC
PMC329642
OpenAlex
W1987392704
Cited by
199
References
43
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 4 · 2021: 7 · 2020: 4 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 2 · 2012: 4
FWCI
3.55
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Temple University
  • National Institutes of Health (AM-36192, 5t32am007162-09, 5r01am034548-03)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
ethanol, insulin resistance, carbohydrate oxidation, fat oxidation, protein oxidation, glucose infusion, glucose appearance, glucose disappearance, glucose-stimulated insulin secretion, hyperinsulinemic-euglycemic clamp, alcohol metabolism, diabetogenic effect, glucose tolerance
MeSH terms
Acetates, Adult, Ethanol, Blood Glucose, Calorimetry, Fatty Acids, Nonesterified, Humans, Insulin, Insulin Resistance, Liver, Male, Oxidation-Reduction, Proteins, Receptor, Insulin, Carbohydrate Metabolism, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review